References
Shrestha D, Szöllősi J, Jenei A. Bare lymphocyte syndrome: An
opportunity to discover our immune system. Immunol Lett .
2012;141(2):147-157.
Griscelli C. Combined immunodeficiency with defective expression in
major histocompatibility complex class II genes. Clin Immunol
Immunopathol . 1991;61(2):S106-S110
Doll R, McGarry D, Jhaveri D, Hostoffer R, Tcheurekdjian H. HETEROZYGOUS
MUTATIONS OF THE MAJOR HISTOCOMPATIBILITY CLASS-II ASSOCIATED MOLECULES.
Annals of Allergy, Asthma & Immunology. 2018;121(5):S100-S101
DeMuthK, Mitchell D, Koenig C, Zhao W, Irani A. Atypicalbare lymphocyte
syndrome due to MHC class II insufficiency. Journal of Allergy and
ClinicalImmunology. 2005;115(2):S83
Reith W, LeibundGut-Landmann S, Waldburger JM. Regulation of MHC class
II gene expression by the class II transactivator. Nat Rev
Immunol 2005: 5 : 793–806.
Dziembowska, Marie-Claude Fondanech M. Three novel mutations of the
CIITA gene in MHC class II-deficient patients with a severe
immunodeficiency. Immunogenetics. 2002;53(10-11):821-829.
Rigg L, Sanan N, Jhaveri D, Tcheurekdjian H. Two Novel Mutations of
Major Histocompatibility Class-II Associated Molecules. Journal of
Clinical Immunology. 2019;39(Suppl 1): 1
Duraes F, Thelemann C, Sarter K, Acha-Orbea H, Hugues S, Reith W. Role
of major histocompatibility complex class II expression by
non-hematopoietic cells in autoimmune and inflammatory disorders: facts
and fiction. Tissue Antigens. 2013;82(1):1-15
Waldburger J, Masternak K, Muhlethaler-Mottet A, Villard J, Peretti M,
Landmann S et al. Lessons from the bare lymphocyte syndrome: molecular
mechanisms regulating MHC class II expression. Immunological Reviews.
2000;178(1):148-165.
Delmonte O, Schuetz C, Notarangelo L. RAG Deficiency: Two Genes, Many
Diseases. Journal of Clinical Immunology. 2018;38(6):646-655